B. Storer

发表

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

M. Sorror, M. Maris, R. Storb, 2005, Blood.

Reference values for cook's distance

Choongrak Kim, B. Storer, Choongrak Kim, 1996 .

Design and analysis of phase I clinical trials.

B E Storer, B. Storer, 1989, Biometrics.

Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.

T. Braun, B. Storer, Stephanie J. Lee, 2014, Blood.

A class of phase II designs with three possible outcomes.

B. Storer, 1992, Biometrics.

"To combine or not to combine": optimizing risk assessment before allogeneic hematopoietic cell transplantation.

M. Sorror, B. Storer, M. Elsawy, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.

R. Storb, B. Storer, F. Appelbaum, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk factors for carcinoma in situ of the breast.

P L Remington, B E Storer, P. Remington, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Lactation and a reduced risk of premenopausal breast cancer

Robert Mittendorf, Matthew P. Longnecker, Walter C. Willett, 1994 .

Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women.

W. Willett, M. Longnecker, J. Baron, 1995, American journal of epidemiology.

Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission.

E. Estey, J. Radich, B. Wood, 2013, Blood.

Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.

H. Deeg, J. Radich, S. Heimfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality.

H. Deeg, R. Storb, B. Sandmaier, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.

H. Deeg, P. Hari, M. Sorror, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning

R. Storb, B. Sandmaier, B. Storer, 2005, Bone Marrow Transplantation.

Ixazomib for treatment of refractory chronic graft vs. host disease: A Chronic GVHD Consortium phase II trial: Ixazomib for chronic GVHD treatment.

W. Wood, B. Storer, J. Pidala, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Carfilzomib for treatment of refractory chronic graft vs. host disease: A Chronic GVHD Consortium pilot phase II trial.

B. Storer, J. Pidala, Stephanie J. Lee, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Providing personalized prognostic information for adult leukemia survivors.

Alan M. Miller, B. Storer, B. George, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013, Blood.

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

B. Storer, J. Pidala, Stephanie J. Lee, 2011, Blood.

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.

R. Storb, B. Storer, F. Appelbaum, 2011, Blood.

Health consensus criteria and for chronic graft-versus-host disease according to National Comparative analysis of risk factors for acute graft-versus-host disease

R. Storb, B. Storer, F. Appelbaum, 2011 .

Therapy with mycophenolate mofetil for refractory acute and chronic graft-versus-host disease

H. Deeg, K. Sullivan, R. Storb, 2009, Bone Marrow Transplantation.

Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens

M. Sorror, R. Storb, B. Sandmaier, 2008, Bone Marrow Transplantation.

Duration of immunosuppressive treatment for chronic graft-versus-host disease.

R. Storb, B. Storer, F. Appelbaum, 2004, Blood.

Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation.

R. Storb, B. Sandmaier, B. Storer, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genetic risk factors for sclerotic graft-versus-host disease.

L. Zhao, B. Storer, E. Warren, 2014, Blood.

Metabolic syndrome appears early after hematopoietic cell transplantation.

M. Bar, B. Storer, K. McMillen, 2014, Metabolic syndrome and related disorders.

Lactation and a reduced risk of premenopausal breast cancer.

W. Willett, M. Longnecker, B. Macmahon, 1994, The New England journal of medicine.

Gallstones in Pediatric Hematopoietic Cell Transplant Survivors With Up to 40 Years of Follow-up

B. Storer, G. McDonald, K. Baker, 2014, Journal of pediatric hematology/oncology.

Impact of Copy Neutral Loss of Heterozygosity and Total Genome Aberrations on Survival in Myelodysplastic Syndrome

H. Deeg, B. Storer, M. Fang, 2017, Modern Pathology.

Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia

H. Deeg, M. Sorror, B. Storer, 2019, Haematologica.

Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia.

H. Deeg, Emily A. Stevens, B. Wood, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base.

V. Sondak, B. Storer, J. Gershenwald, 2016, Journal of the National Cancer Institute.

Cancer of the large bowel in women in relation to alcohol consumption: a case-control study in Wisconsin (United States)

P. Newcomb, P. Marcus, B. Storer, 1993, Cancer Causes & Control.

Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease.

B. Storer, C. Chesnut, J. Sanders, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

M. Maris, R. Storb, B. Sandmaier, 2007, Blood.

W. Wood, B. Storer, J. Pidala, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants.

B. Storer, D. Madtes, R. Hackman, 2003, Blood.

malignancies nonmyeloablative conditioning for patients with hematologic HLA-matched unrelated donor hematopoietic cell transplantation after

S. Heimfeld, M. Maris, B. Sandmaier, 2013 .

Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.

M. Sorror, R. Storb, B. Sandmaier, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning.

M. Maris, R. Storb, B. Sandmaier, 2003, Experimental hematology.

Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly.

B. Storer, J. Schiller, R. Proctor, 1991, Cancer research.

Comorbidities, alcohol use disorder, and age predict outcomes following autologous hematopoietic cell transplantation for lymphoma

M. Sorror, R. Storb, D. Maloney, 2016 .

Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation.

M. Sorror, R. Storb, B. Sandmaier, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nonrandom chromosome losses in stepwise neoplastic transformation in vitro of human uroepithelial cells.

B. Storer, C. Reznikoff, K. Gilchrist, 1991, Cancer research.

Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer.

R. Vessella, P. Lange, B. Storer, 2000, The Journal of urology.

Title : Association between Acute and Chronic Graft -Versus-Host Disease and Bronchiolitis Obliterans Organizing Pneumonia in Recipients of Hematopoietic Stem Cell Transplants Running Head : BOOP and Graft -Versus -Host Disease

B. Storer, D. Madtes, R. Hackman, 2003 .

total body irradiation for relapsed and refractory mantle cell lymphoma Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy

R. Storb, B. Sandmaier, B. Storer, 2013 .

Lactation and a reduced risk of premenopausal breast cancer.

W. Willett, M. Longnecker, B. Macmahon, 1994, The New England journal of medicine.

POSTMENOPAUSAL HORMONE USE AND RISK OF LARGE-BOWEL CANCER

P. Newcomb, B. Storer, 1996 .

EXCESS OF MALIGNANT MELANOMAS IN WOMEN IN THE BRITISH ISLES

B. Storer, JohnA. H. Lee, 1980, The Lancet.

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia

M. Maris, R. Storb, B. Sandmaier, 2011, Haematologica.

Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.

B. Storer, Anajane G. Smith, J. Hansen, 2001, The New England journal of medicine.

transplantation for severe aplastic anemia Late effects among pediatric patients followed for nearly 4 decades after

R. Storb, B. Storer, J. Sanders, 2013 .

Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia.

H. Deeg, R. Storb, B. Storer, 2011, Blood.

Competing Interests: The authors

B. Storer, R. Humphries, H. Kiem, 2004 .

Endocrine dysfunction in p27Kip1 deficient mice and susceptibility to Wnt-1 driven breast cancer.

B. Storer, C. Kemp, K. Gurley, 2009, Carcinogenesis.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report.

B. Storer, G. Armstrong, S. Bhatia, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Research Methodology and Study Design

B. Storer, S. Bhatia, B. Shaw, 2016 .

Thyroid function following hematopoietic cell transplantation in children: 30 years' experience.

R. Storb, B. Storer, F. Appelbaum, 2009, Blood.

Second allogeneic hematopoietic cell transplantation for relapse after first allografts

R. Storb, B. Sandmaier, D. Maloney, 2019, Leukemia & lymphoma.

Long-term survival among men with conservatively treated localized prostate cancer.

D. Fryback, B. Storer, P. Albertsen, 1995, JAMA.

Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma.

R. Storb, B. Sandmaier, D. Maloney, 2017, Blood advances.

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.

B. Storer, T. Panzarella, M. Aljurf, 2016, Blood.

Confounding Factors Affecting the National Institutes of Health (NIH) Chronic Graft-Versus-Host Disease Organ-Specific Score and Global Severity

B. Sandmaier, B. Storer, Stephanie J. Lee, 2016, Bone Marrow Transplantation.

BK virus infection in hematopoietic stem cell transplant recipients: frequency, risk factors, and association with postengraftment hemorrhagic cystitis.

B. Storer, A. Limaye, M. Boeckh, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

transplantation Factors affecting antibody levels after allogeneic hematopoietic cell

D. Maloney, B. Storer, M. Boeckh, 2011 .

Factors affecting antibody levels after allogeneic hematopoietic cell transplantation.

D. Maloney, B. Storer, M. Boeckh, 2003, Blood.

Clinical and biologic effects of combination therapy with gamma‐interferon and tumor necrosis factor

B. Storer, E. Borden, J. Schiller, 1992, Cancer.

Clinical and immunological effects of treatment with murine anti-CD3 monoclonal antibody along with interleukin 2 in patients with cancer.

R. Bechhofer, B. Storer, J. Schiller, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant

B. Storer, W. Leisenring, G. McDonald, 2007, Bone Marrow Transplantation.

Body size and risk of breast cancer.

W. Willett, M. Longnecker, J. Baron, 1997, American journal of epidemiology.

Human T cells in hu‐PBL‐SCID mice proliferate in response to Daudi lymphoma and confer anti‐tumour immunity

B. Storer, V. Malkovska, F. Cigel, 1994, Clinical and experimental immunology.

Antilymphoma Activity of Human γδ T-Cells in Mice with Severe Combined Immune Deficiency

B. Storer, N. Armstrong, R. Hong, 1992 .

FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease1

R. Storb, B. Storer, M. Loken, 2003, Transplantation.

What role for FTY720, a novel immunosuppressive agent, in canine nonmyeloablative hematopoietic stem cell transplantation?

R. Storb, B. Storer, J. Zaucha, 2002, Transplantation.

A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.

B. Storer, E. Borden, J. Schiller, 1990, The Journal of clinical investigation.

The Chronic Graft-vs.-Host Disease Failure-Free Survival (cGVHD-FFS) index.

B. Storer, J. Pidala, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease.

D. Miklos, B. Storer, Jingxin Qiu, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2017, Blood.

Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.

B. Storer, J. Pidala, Stephanie J. Lee, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bandage Soft Contact Lenses for Ocular Graft-versus-Host Disease.

Ruikang K. Wang, Tueng T. Shen, B. Storer, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.

B. Storer, K. van Besien, Stephanie J. Lee, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison between short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease

B. Storer, Stephanie J. Lee, D. Couriel, 2011 .

M. Maris, R. Storb, F. Baron, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes

Ming-Tseh Lin, B. Storer, J. Hansen, 2008, Immunologic research.

Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors

B. Storer, M. Remberger, O. Ringdén, 2002, Bone Marrow Transplantation.

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma

P. Hari, R. Storb, B. Sandmaier, 2018, Haematologica.

Prolonged interleukin-2 (IL-2) treatment can augment immune activation without enhancing antitumor activity in renal cell carcinoma.

R. Bechhofer, J. Sosman, B. Storer, 1991, Cancer investigation.

Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer.

R. Bechhofer, J. Sosman, B. Storer, 1988, Cancer research.

In vivo induction of the lymphokine-activated killer phenomenon: interleukin 2-dependent human non-major histocompatibility complex-restricted cytotoxicity generated in vivo during administration of human recombinant interleukin 2.

R. Bechhofer, B. Storer, J. Bradshaw, 1988, Cancer research.

Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicity.

R. Bechhofer, J. Sosman, B. Storer, 1988, Journal of the National Cancer Institute.

Phase I Trials

B. Storer, 2005 .

Tumor-infiltrating lymphocytes and interleukin-2 in melanomas.

J. Sosman, B. Storer, J. Hank, 1989, The New England journal of medicine.

Systemic interleukin-2 modulates the anti-idiotypic response to chimeric anti-GD2 antibody in patients with melanoma.

B. Storer, J. Schiller, M. Albertini, 1996, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Clinical and Immunological Effects of Recombinant Interleukin 2 Given by Repetitive Weekly Cycles to Patients with Cancer 1

R. Bechhofer, J. Sosman, B. Storer, 2006 .

the influence of autologous lymphokine‐activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin‐2

R. Bechhofer, J. Sosman, B. Storer, 1990, Cancer.

Phase 1 clinical trial of recombinant interleukin-2: a comparison of bolus and continuous intravenous infusion.

R. Bechhofer, B. Storer, K. Moore, 1989, Cancer investigation.

Application of CIBMTR risk score to NIH chronic GVHD at individual centers.

B. Storer, J. Lipton, J. Kuruvilla, 2014, Blood.

Impact of acute kidney injury on long-term mortality after nonmyeloablative hematopoietic cell transplantation.

M. Sorror, R. Storb, B. Sandmaier, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation after ﬂudarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

M. Maris, R. Storb, B. Sandmaier, 2004 .

The association between donor and recipient statin use and infections after allogeneic hematopoietic cell transplantation

B. Sandmaier, B. Storer, M. Boeckh, 2015, Bone Marrow Transplantation.

Immunomodulatory Effects of Mixed Hematopoietic Chimerism: Immune Tolerance in Canine Model of Lung Transplantation

R. Glenny, S. Ziegler, H. Ochs, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

J. Radich, M. Maris, R. Storb, 2005 .

Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimens.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013, The oncologist.

Conditioning Regimens Costs of Allogeneic Hematopoietic Cell Transplantation Using Reduced Intensity

B. Sandmaier, B. Storer, N. Khera, 2014 .

Early Mixed Lymphoid Donor/Host Chimerism is Associated with Improved Transplant Outcome in Patients with Primary or Secondary Myelofibrosis.

H. Deeg, C. McFarland, B. Storer, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Response of Steroid-Refractory Acute GVHD to α1-Antitrypsin.

B. Storer, C. Dinarello, J. Hansen, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A novel soluble form of Tim-3 associated with severe graft-versus-host disease.

S. Hanash, B. Storer, Chee-Hong Wong, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity

D. Maloney, B. Storer, J. Pagel, 2015, Leukemia & lymphoma.

autografts for the treatment of patients with multiple myeloma Allografting with nonmyeloablative conditioning following cytoreductive

R. Storb, D. Maloney, B. Storer, 2013 .

Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor.

R. Storb, B. Storer, F. Appelbaum, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MALIGNANT MELANOMA FEMALE/MALE DEATH RATIOS

B. Storer, JohnA. H. Lee, 1981, The Lancet.

Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients.

R. Bechhofer, B. Storer, J. Schiller, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Pharmacokinetic and pharmacodynamic analysis of inosine monophosphate dehydrogenase activity in hematopoietic cell transplantation recipients treated with mycophenolate mofetil.

Brian R. Phillips, B. Sandmaier, B. Storer, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.

J. Fay, B. Storer, J. Wingard, 2009, Blood.

Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasms

R. Storb, F. Baron, B. Sandmaier, 2019, Haematologica.

CD 45 antibody for conditioning in allogeneic − astatine-211-emitter α Durable donor engraftment after radioimmunotherapy using

R. Storb, B. Sandmaier, B. Storer, 2012 .

Repetitive weekly cycles of interleukin-2. II. Clinical and immunologic effects of dose, schedule, and addition of indomethacin.

R. Bechhofer, J. Sosman, B. Storer, 1988, Journal of the National Cancer Institute.

Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation

B. Wood, B. Sandmaier, B. Storer, 2012, Cancer.

Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation.

E. Estey, B. Sandmaier, B. Storer, 2011, Blood.

A preclinical model of double- versus single-unit unrelated cord blood transplantation.

S. Heimfeld, R. Storb, B. Storer, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.

M. Maris, R. Storb, B. Sandmaier, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensive Versus Non-Intensive Induction Therapy for Patients (Pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) Using Two Different Novel Prognostic Models

E. Estey, M. Sorror, B. Sandmaier, 2016 .

Impact of cranial irradiation added to intrathecal conditioning in hematopoietic cell transplantation in adult acute myeloid leukemia with central nervous system involvement.

R. Storb, B. Storer, F. Appelbaum, 2011, International journal of radiation oncology, biology, physics.

Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes.

R. Storb, B. Storer, F. Appelbaum, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia.

H. Deeg, R. Storb, B. Storer, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome.

R. Storb, B. Storer, F. Appelbaum, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.

M. Maris, R. Storb, B. Sandmaier, 2004, Blood.

Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013, Blood.

TRANSPLANTATION Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013 .

Activation and expansion of CD8(+) T effector cells in patients with chronic graft-versus-host disease.

B. Storer, E. Warren, Stephanie J. Lee, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hepatitis C virus infection and bone marrow transplantation: A cohort study with 10‐year follow‐up

K. Sullivan, B. Storer, M. Flowers, 1999, Hepatology.

Cirrhosis of the liver in long-term marrow transplant survivors.

K. Sullivan, B. Storer, G. McDonald, 1999, Blood.

Comparison of Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning with HLA-Matched Related (MRD), Unrelated (URD), and Related Haploidentical (Haplo) Donors for Relapsed or Refractory Hodgkin Lymphoma (HL).

M. Maris, R. Storb, B. Sandmaier, 2007 .

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.

M. Maris, R. Storb, B. Sandmaier, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.

M. Sorror, R. Storb, B. Sandmaier, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Number of Courses of Induction Therapy Independently Predicts Outcome after Allogeneic Transplantation for AML in First Morphological Remission

H. Deeg, M. Sorror, R. Storb, 2015 .

Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.

M. Maris, R. Storb, B. Sandmaier, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia.

J. Radich, B. Storer, F. Appelbaum, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience

P. Hari, M. Sorror, M. Maris, 2019, Bone Marrow Transplantation.

Clofarabine with high dose cytarabine and granulocyte colony‐stimulating factor (G‐CSF) priming for relapsed and refractory acute myeloid leukaemia

E. Estey, B. Storer, D. Stirewalt, 2011, British journal of haematology.

Multivariate Analysis of Response and Survival After Treatment with Clofarabine, Cytarabine and G-CSF Priming (GCLAC) In Relapsed/Refractory Acute Myeloid Leukemia (AML): Comparison with Prior Experience Using Fludarabine and Cytarabine Combination Regimens.

E. Estey, B. Storer, D. Stirewalt, 2010 .

Therapy of Myelodysplastic Syndrome (MDS) with Azacitidine Given in Combination with Etanercept: A Phase II Study.

B. Storer, S. Petersdorf, A. Ramakrishnan, 2007 .

Validation of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in single and multiple institutions: limitations and inferences.

M. Sorror, R. Storb, B. Storer, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation.

S. Heimfeld, R. Storb, B. Sandmaier, 2009, Blood.

Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy.

R. Collins, H. Deeg, S. Feig, 2006, Blood.

Cutaneous macrophage infiltration in acute GvHD

B. Storer, P. Martin, H. Shulman, 2015, Bone Marrow Transplantation.

A pilot pharmacologic biomarker study of busulfan and fludarabine in hematopoietic cell transplant recipients

S. Heimfeld, B. Storer, Joanne Wang, 2011, Cancer Chemotherapy and Pharmacology.

Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease.

B. Storer, J. Hansen, G. McDonald, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors of acute GVHD treatment outcomes 1 PREDICTIVE VALUE OF CLINICAL FINDINGS AND PLASMA BIOMARKERS AFTER 14 DAYS OF PREDNISONE TREATMENT FOR ACUTE GRAFT-VERSUS-HOST DISEASE

B. Storer, J. Hansen, G. McDonald, 2017 .

Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment.

B. Storer, J. Hansen, G. McDonald, 2015, Blood.

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.

R. Storb, B. Storer, F. Appelbaum, 2009, Blood.

Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation.

R. Storb, B. Sandmaier, D. Maloney, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sirolimus Combined with Mycophenolate Mofetil (MMF) and Cyclosporine (CSP) Significantly Improves Prevention of Acute Graft-Versus-Host-Disease (GVHD) after Unrelated Hematopoietic Cell Transplantation (HCT): Results from a Phase III Randomized Multi-Center Trial

M. Maris, R. Storb, B. Sandmaier, 2016 .

The Use of Ex Vivo Generated Regulatory T-Cell Preparations in a Canine Lung Allograft Model.

B. Storer, D. Madtes, R. Nash, 2017, Transplantation.

Simultaneous Transplantation of Hematopoietic Stem Cells and a Vascularized Composite Allograft Leads to Tolerance

R. Storb, B. Storer, D. Mathes, 2014, Transplantation.

Tolerance to Vascularized Composite Allografts in Canine Mixed Hematopoietic Chimeras

R. Storb, B. Storer, R. Nash, 2011, Transplantation.

Partial Donor-Specific Tolerance to Delayed Skin Grafts After Rejection of Hematopoietic Cell Graft

R. Storb, B. Storer, R. Nash, 2006, Transplantation.

The in vitro function of lymphocytes from 25 cancer patients receiving four to seven consecutive days of recombinant IL-2.

R. Bechhofer, B. Storer, N. Rosenthal, 1988, Journal of biological response modifiers.

Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen mismatched donors.

M. Maris, R. Storb, B. Sandmaier, 2020, Blood.

Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-versus-lymphoma effect

R. Storb, B. Sandmaier, D. Maloney, 2018, Haematologica.

Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial.

M. Bar, R. Storb, B. Sandmaier, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of donor age on outcome after allogeneic hematopoietic cell transplantation.

R. Storb, B. Sandmaier, D. Maloney, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation.

R. Storb, B. Storer, F. Appelbaum, 2011, Blood.

A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.

R. Storb, B. Storer, F. Appelbaum, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic factors and outcomes of severe gastrointestinal graft-vs.-host disease after allogeneic hematopoietic cell transplantation

R. Storb, B. Storer, F. Appelbaum, 2014, Bone Marrow Transplantation.

Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease

R. Storb, B. Storer, M. Mielcarek, 2014, Haematologica.

Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.

R. Storb, B. Sandmaier, D. Maloney, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.

B. Storer, F. Appelbaum, E. Warren, 2009, Blood.

Failure-free survival after initial systemic treatment of chronic graft-versus-host disease.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2014, Blood.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2018, Haematologica.

Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease.

M. Bar, B. Storer, Stephanie J. Lee, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors.

W. Wood, B. Storer, J. Pidala, 2016, Blood.

Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia.

K. Sullivan, R. Storb, B. Storer, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation.

T. Hohl, B. Storer, E. Warren, 2017, Blood.

Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.

E. Estey, M. Bar, B. Wood, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required.

R. Storb, B. Storer, J. Zaucha, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.

Nathan H. Roy, Philip R. Gafken, Y. Ogata, 2018, Blood.

Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes.

B. Storer, G. McDonald, J. McCune, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic GVHD

B. Storer, J. Pidala, Stephanie J. Lee, 2019 .

Plasma lipoprotein changes in humans induced by beta-interferon.

B. Storer, E. Borden, D. Wiebe, 1987, Atherosclerosis.

onmyeloablative Unrelated Donor Hematopoietic Cell ransplantation to Treat Patients with Poor-Risk , elapsed , or Refractory Multiple Myeloma

M. Sorror, M. Maris, R. Storb, 2007 .

A direct comparison of immunological and clinical effects of interleukin 2 with and without interferon-alpha in humans.

R. Bechhofer, B. Storer, J. Schiller, 1993, Cancer research.

Biological and Clinical Effects of the Combination of β- and γ-Interferons Administered as a 5-Day Continuous Infusion

B. Storer, E. Borden, J. Schiller, 1990 .

Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.

B. Storer, E. Borden, J. Schiller, 1990, Cancer research.

Impact of Comorbidities at Diagnosis of Acute Myeloid Leukemia on One-Year Mortality

E. Estey, M. Sorror, B. Storer, 2015 .

Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-beta.

B. Storer, E. Borden, R. Brown, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

J Crowley, B E Storer, T A Gooley, 1999, Statistics in medicine.

Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin

H. Deeg, C. McFarland, M. Sorror, 2021, Bone Marrow Transplantation.

Association of fludarabine pharmacokinetic/dynamic biomarkers with donor chimerism in nonmyeloablative HCT recipients

S. Heimfeld, B. Sandmaier, B. Storer, 2015, Cancer Chemotherapy and Pharmacology.

Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation.

Brian R. Phillips, B. Sandmaier, B. Storer, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treosulfan, Fludarabine and 2 Gy Total Body Irradiation Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with MDS and AML

E. Estey, M. Bar, B. Wood, 2014 .

Nonrelapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation.

B. Sandmaier, B. Storer, M. Boeckh, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

chronic GVHD Evaluation of NIH consensus criteria for classification of late acute and

B. Storer, F. Appelbaum, E. Warren, 2009 .

prednisone does not compromise patient outcomes Initial therapy of acute graft-versus-host disease with low-dose

R. Storb, B. Storer, F. Appelbaum, 2009 .

Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.

B. Storer, F. Appelbaum, E. Warren, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.

M. Sorror, M. Maris, R. Storb, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

RECIPIENT PRETRANSPLANT INOSINE MONOPHOSPHATE DEHYDROGENASE ACTIVITY IN NONMYELOABLATIVE HCT

Brian R. Phillips, B. Sandmaier, B. Storer, 2014 .

Breast self-examination in relation to the occurrence of advanced breast cancer.

P. Newcomb, B. Storer, N. Weiss, 1991, Journal of the National Cancer Institute.

Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer

P. Nelson, J. Davison, R. Vessella, 2016, Epigenetics.

Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation

B. Storer, J. Hansen, S. Spellman, 2022, Blood advances.

Comorbidity Burden in Patients with Chronic Graft Versus Host Disease

W. Wood, B. Storer, J. Pidala, 2014 .

Recombinant human macrophage colony‐stimulating factor‐induced thrombocytopenia in dogs

W. Nelp, R. Storb, B. Storer, 2003, British journal of haematology.

Toxicity and efficacy of daily dapsone as Pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: a case-control study.

B. Storer, M. Boeckh, L. Corey, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic Kidney Disease Following Non‐Myeloablative Hematopoietic Cell Transplantation

R. Storb, B. Sandmaier, B. Storer, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation.

D. Maloney, B. Storer, J. Storek, 2001, Blood.

allogeneic hematopoietic cell transplantation: a study of 193 patients Hepatic injury after nonmyeloablative conditioning followed by

M. Maris, R. Storb, B. Sandmaier, 2013 .

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells.

H. Deeg, J. Radich, B. Storer, 2003, Blood.

Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.

K. Sullivan, R. Storb, B. Storer, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence.

J. Potter, P. Newcomb, B. Storer, 2003, Journal of the National Cancer Institute.

Hematopoietic stem cell engraftment: a direct comparison between intramarrow and intravenous injection in nonhuman primates.

B. Storer, T. Neff, C. Jung, 2007, Experimental Hematology.

Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation.

R. Storb, B. Storer, F. Appelbaum, 2016, Blood.

allogeneic hematopoietic stem cells Conditioning with fludarabine and targeted busulfan for transplantation of

J. Radich, B. Storer, F. Appelbaum, 2013 .

Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation.

R. Collins, H. Deeg, S. Feig, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GVHD?

S. Heimfeld, P. Hari, R. Storb, 2016, Bone Marrow Transplantation.

M. Maris, R. Storb, B. Sandmaier, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiation.

R. Storb, B. Sandmaier, B. Storer, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allo-SCT for multiple myeloma: a review of outcomes at a single transplant center

R. Storb, B. Sandmaier, D. Maloney, 2012, Bone Marrow Transplantation.

Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.

M. Sorror, M. Maris, R. Storb, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nonmyeloablative Unrelated Donor Hematopoietic Cell Transplantation for the Treatment of Patients with Poor-Risk, Relapsed or Refractory Multiple Myeloma

M. Sorror, M. Maris, R. Storb, 2007 .

Nonmyeloablative Unrelated Donor (URD) Hematopoietic Cell Transplantation (HCT) for the Treatment of Patients (pts) with Poor-Risk, Relapsed or Refractory Multiple Myeloma.

M. Sorror, M. Maris, R. Storb, 2005 .

Keratinocyte dysplasia in hematopoietic stem cell transplantation recipients in the day-28-to-84 posttransplantation period.

Z. Argényi, B. Storer, K. Guthrie, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Physician-diagnosed depression and suicides in pediatric hematopoietic cell transplant survivors with up to 40 years of follow-up

B. Storer, K. Syrjala, K. Baker, 2016, Bone Marrow Transplantation.

Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.

B. Storer, A. Kariminia, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Depressed in vitro T cell responses concomitant with augmented interleukin-2 responses by lymphocytes from cancer patients following in vivo treatment with interleukin-2.

R. Bechhofer, J. Sosman, B. Storer, 1990, Journal of biological response modifiers.

Adjusted estimates for time-to-event endpoints

B. Storer, Michael P. Jones, T. Gooley, 2008, Lifetime data analysis.

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

P. Hari, M. Maris, R. Storb, 2014, Haematologica.

Allogeneic hematopoietic cell transplantation in the outpatient setting.

R. Storb, B. Sandmaier, B. Storer, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.

M. Sorror, M. Maris, R. Storb, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of oral beclomethasone dipropionate for prevention of acute graft-versus-host disease.

B. Storer, S. Pergam, Paul J. Martin, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Role of Comorbidities in Prognostic Evaluation of Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) from HLA-Mismatched (MM) and Umbilical Cord Blood (UCB) Donor Grafts

M. Sorror, R. Storb, B. Sandmaier, 2014 .

Association of Pre-Transplant Comorbidities with Long-Term Quality of Life (QOL) Among Survivors After Allogeneic Hematopoietic Cell Transplantation (HCT)

M. Sorror, R. Storb, B. Storer, 2013 .

Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose.

M. Bar, P. Hari, R. Storb, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.

T. Torgerson, R. Storb, B. Storer, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Validation of the predictive power of the hematopoietic cell transplantation-comorbidity index (HCT-CI) for non-relapse mortality (NRM) and survival after allogeneic HCT

M. Sorror, M. Maris, R. Storb, 2006 .

Clinical testing of IL-2: in vivo administration of IL-2 induces IL-2 dependent non-MHC-restricted cytotoxicity (NRC).

B. Storer, N. Rosenthal, K. Moore, 1987, Progress in clinical and biological research.

Comparing high and low total body irradiation dose rates for minimum-intensity conditioning of dogs for dog leukocyte antigen-identical bone marrow grafts.

R. Storb, B. Storer, Tiffany M Butts, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comorbidity burden in patients with chronic GVHD

W. Wood, B. Storer, J. Pidala, 2013, Bone Marrow Transplantation.

Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.

B. Storer, J. Sanders, K. Baker, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diabetes Mellitus in Long-Term Survivors of Pediatric Hematopoietic Cell Transplantation

B. Storer, J. Sanders, P. Hoffmeister, 2004, Journal of pediatric hematology/oncology.

Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis

H. Deeg, M. Sorror, R. Storb, 2006, Leukemia.

Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial.

P. Hari, R. Storb, B. Sandmaier, 2013, Biology of Blood and Marrow Transplantation.

Comparison of Minimal Residual Disease as Outcome Predictor for AML Patients in First Complete Remission Undergoing Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

B. Wood, M. Sorror, R. Storb, 2013, Leukemia.

A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation

W. Wood, D. Miklos, B. Storer, 2015, Clinical Cancer Research.

Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.

R. Storb, D. Maloney, B. Storer, 2001, Blood.

Primary Mantle Cell Lymphoma Cell Cultures Soluble Cd40 Ligand Induces Selective Proliferation of Lymphoma Cells In

D. Maloney, B. Storer, M. Lanotte, 2022 .

Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma.

V. Sondak, B. Storer, J. Gershenwald, 2014, Journal of the American Academy of Dermatology.

Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children.

B. Storer, F. Appelbaum, J. Hansen, 2002, Blood.

Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.

B. Storer, M. Boeckh, J. Zaia, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Success of allogeneic marrow transplantation for children with severe aplastic anaemia

H. Deeg, R. Storb, B. Storer, 2012, British journal of haematology.

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: improved outcomes over two decades

P. Hari, M. Sorror, M. Maris, 2020, Haematologica.

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

R. Storb, B. Storer, M. Boeckh, 2015, Haematologica.

Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs

R. Storb, B. Sandmaier, D. Maloney, 2011, Haematologica.

Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.

J. Radich, M. Sorror, M. Maris, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.

E. Estey, M. Sorror, M. Maris, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system.

V. Sondak, M. Ross, B. Storer, 2010, Journal of the American Academy of Dermatology.

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma.

M. Maris, R. Storb, B. Sandmaier, 2004, Blood.

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.

R. Storb, B. Storer, F. Appelbaum, 2002, Blood.

Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

M. Sorror, R. Storb, B. Sandmaier, 2008, Cancer.

Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.

H. Deeg, M. Sorror, M. Maris, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biological and Clinical Effects of Interferon-βser at Two Doses

B. Storer, E. Borden, D. Trump, 1990 .

Absence of Biological Effects of Orally Administered Interferon-βser

B. Storer, E. Borden, S. Grossberg, 1992 .

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.

R. Storb, B. Sandmaier, D. Maloney, 2004, Blood.

Chromosomal instability in pancreatic ductal cells from patients with chronic pancreatitis and pancreatic adenocarcinoma

J. Potter, M. Bronner, P. Rabinovitch, 2003, Genes, chromosomes & cancer.

Postmenopausal estrogen and progestin use in relation to breast cancer risk.

W. Willett, M. Stampfer, J. Baron, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide.

B. Storer, H. Robins, E. Warren, 2016, JCI insight.

Langerhans Cell Homeostasis and Turnover After Nonmyeloablative and Myeloablative Allogeneic Hematopoietic Cell Transplantation

M. Merad, B. Wood, R. Storb, 2014, Transplantation.

High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation

S. Heimfeld, J. Panse, M. Sorror, 2005, Leukemia.

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.

C. Flowers, M. Sorror, M. Maris, 2004, Blood.

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.

C. Flowers, M. Sorror, M. Maris, 2004, Blood.

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.

R. Storb, B. Sandmaier, D. Maloney, 2003, Blood.

Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.

H. Deeg, K. Sullivan, R. Storb, 1997, Blood.

Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma.

R. Fanin, A. Levis, M. Boccadoro, 2010, Blood.

Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.

P. Hari, M. Sorror, R. Storb, 2009, Blood.

Evaluation of published single nucleotide polymorphisms associated with acute GVHD.

L. Zhao, B. Storer, E. Warren, 2012, Blood.

IL10 and IL10 Receptor Gene Variation and Outcomes After Unrelated and Related Hematopoietic Cell Transplantation

L. Zhao, Ming-Tseh Lin, B. Storer, 2009, Transplantation.

Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation.

Ming-Tseh Lin, B. Storer, J. Hansen, 2003, The New England journal of medicine.

Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia

E. Estey, J. Davison, S. Heimfeld, 2015, Epigenetics.

Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.

M. Maris, R. Storb, B. Sandmaier, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

DLA-DQB1 alleles and bone marrow transplantation experiments in narcoleptic dogs.

E. Mignot, R. Storb, B. Storer, 2000, Tissue antigens.

Effect of Segment Length on Risk for Neoplastic Progression in Patients with Barrett Esophagus

B. Reid, R. Haggitt, B. Storer, 2000, Annals of Internal Medicine.

Treatment of recurrent platinum resistant ovarian or peritoneal cancer with gemcitabine and doxorubicin: A phase I/II trial of the Puget Sound Oncology Consortium (PSOC 1602).

B. Storer, B. Goff, A. Jacobs, 2003, American journal of obstetrics and gynecology.

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.

S. Heimfeld, M. Maris, R. Storb, 2003, Blood.

Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine.

B. Storer, E. Borden, R. Brown, 1989, Journal of the National Cancer Institute.

A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell Transplantation

Benjamin D. Heavner, B. Storer, D. Geraghty, 2021, Frontiers in Immunology.

A disease risk index for patients undergoing allogeneic stem cell transplantation.

H. Deeg, J. Ritz, M. Sorror, 2012, Blood.

Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT.

L. Zhao, B. Storer, E. Warren, 2012, Blood.

Screening sigmoidoscopy and colorectal cancer mortality.

B E Storer, P. Newcomb, P. Marcus, 1992, Journal of the National Cancer Institute.

Marital adjustment, satisfaction and dissolution among hematopoietic stem cell transplant patients and spouses: a prospective, five‐year longitudinal investigation

B. Storer, S. Langer, K. Syrjala, 2010, Psycho-oncology.

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissio

R. Storb, B. Sandmaier, D. Maloney, 2003, Blood.

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.

R Storb, S. Heimfeld, R. Storb, 2001, The New England journal of medicine.

Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose.

R Storb, C Anasetti, K. Sullivan, 1997, Blood.

Pregnancy Termination and Risk of Breast Cancer-Reply

W. Willett, M. Longnecker, P. Newcomb, 1996 .

J. Sierra, R. Storb, B. Storer, 2000, Bone Marrow Transplantation.

A sequential phase II/III trial for binary outcomes.

B E Storer, B. Storer, 1990, Statistics in medicine.

Limiting the daily total nucleated cell dose of cryopreserved peripheral blood stem cell products for autologous transplantation improves infusion-related safety with no adverse impact on hematopoietic engraftment.

S. Heimfeld, B. Storer, Stephanie J. Lee, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic utility of routine chimerism testing at 2 to 6 months after allogeneic hematopoietic cell transplantation.

B. Storer, Ghada I. Mossallam, A. Kamel, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cytomegalovirus viral load and virus-specific immune reconstitution after peripheral blood stem cell versus bone marrow transplantation.

B. Storer, S. Riddell, T. Stevens-Ayers, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.

M. Sorror, M. Maris, R. Storb, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.

B. Storer, P. Westervelt, F. Appelbaum, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation1

D. Douek, D. Maloney, B. Storer, 2002, Transplantation.

Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls.

B. Storer, S. Langer, K. Syrjala, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anaplastic Wilms' tumor: clinical and pathologic studies.

B. Storer, V. Farewell, J. Bonadio, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors

M. Maris, R. Storb, B. Sandmaier, 2006 .

Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning for Relapsed or Refractory Follicular Lymphoma.

M. Maris, R. Storb, B. Sandmaier, 2005 .

Radiation dose determines the degree of myeloid engraftment after nonmyeloablative stem cell transplantation.

B. Storer, M. Mielcarek, B. Torok-Storb, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

IMPDH pharmacogenetics in hematopoietic cell transplantation patients

B. Sandmaier, B. Storer, J. McCune, 2019 .

Inosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation Patients.

B. Sandmaier, B. Storer, J. McCune, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.

H. Deeg, R. Storb, B. Storer, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma.

B. Storer, S. Langer, K. Syrjala, 2004, JAMA.

Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation.

R. Storb, B. Sandmaier, D. Maloney, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

H. Deeg, J. Radich, R. Storb, 2002, Blood.

Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial.

J. Panse, M. Maris, R. Storb, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term Outcome of Patients with Multiple Myeloma after Autologous Hematopoietic Cell Transplantation and Nonmyeloablative Allografting Running title: Auto-Allotransplant in Multiple Myeloma

P. Hari, M. Sorror, R. Storb, 2008 .

Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.

B. Storer, J. Pidala, Stephanie J. Lee, 2016, Annals of the American Thoracic Society.

Phase I/II multisite trial of optimally dosed clofarabine and low‐dose TBI for hematopoietic cell transplantation in acute myeloid leukemia

E. Estey, J. Radich, R. Storb, 2019, American journal of hematology.

The Quality of Life of Adult Survivors of Childhood Hematopoietic Cell Transplant

R. Storb, B. Storer, F. Appelbaum, 2009, Bone Marrow Transplantation.

Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease.

S. Hanash, B. Storer, Stephanie J. Lee, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nonmyeloablative Conditioning Followed by Allogeneic Marrow Grafts for Treatment of Primary Immune Deficiency Disorders: Preliminary Results of a Phase II Study

H. Ochs, T. Torgerson, R. Storb, 2011 .

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.

P. Hari, M. Sorror, M. Maris, 2011, JAMA.

Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes after Allogeneic Transplantation.

M. Sorror, R. Storb, B. Sandmaier, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.

M. Sorror, R. Storb, B. Sandmaier, 2007, Blood.

Multi-Site 11-Year Experience of Less-Intensive versus Intensive Therapies in Acute Myeloid Leukemia.

E. Estey, M. Sorror, B. Sandmaier, 2021, Blood.

Development and Validation of a Novel Acute Myeloid Leukemia–Composite Model to Estimate Risks of Mortality

E. Estey, M. Sorror, B. Storer, 2017, JAMA oncology.

p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility.

Z. Argényi, B. Storer, P. Nghiem, 2013, American journal of clinical pathology.

Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation.

R. Storb, B. Sandmaier, B. Storer, 2012, Blood.

Prognostic significance of acquired copy‐neutral loss of heterozygosity in acute myeloid leukemia

E. Estey, B. Storer, F. Appelbaum, 2015, Cancer.

Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasia.

B. Storer, F. Appelbaum, R. Hackman, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

An evaluation of phase I clinical trial designs in the continuous dose–response setting

B E Storer, B. Storer, 2001, Statistics in medicine.

Cigarette smoking and breast cancer.

M. Longnecker, J. Baron, P. Newcomb, 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients.

D. Silbergeld, D. Born, K. Swanson, 2014, The Journal of clinical investigation.

Altered tryptophan and neopterin metabolism in cancer patients treated with recombinant interleukin 2.

B E Storer, B. Storer, R. Brown, 1989, Cancer research.

Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease

B. Storer, J. Pidala, Stephanie J. Lee, 2014, Haematologica.

Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Haematologica.

Costs of Second Allogeneic Hematopoietic Cell Transplantation

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013, Transplantation.

The impact of co-morbidity on life expectancy among men with localized prostate cancer.

D. Fryback, B. Storer, P. Albertsen, 1996, The Journal of urology.

Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow.

R. Storb, B. Storer, F. Appelbaum, 2012, Blood.

Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes

H. Deeg, B. Storer, Janghee Woo, 2017, Haematologica.

A Diagnostic for Cox Regression and General Conditional Likelihoods

J. Crowley, B. Storer, John Crowley, 1985 .

Biomarker Panel for Chronic Graft-Versus-Host Disease.

Philip R. Gafken, Y. Ogata, B. Storer, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States)

M. Longnecker, J. Potter, J. Baron, 2003, Cancer Causes & Control.

Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.

M. Sorror, R. Storb, B. Sandmaier, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Biomarker Panel for Chronic Graft-Versus-Host Disease

Y. Ogata, B. Storer, Qing Zhang, 2015 .

Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.

Sarah C. Nelson, B. Storer, E. Warren, 2017, Blood.

Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome.

M. Maris, R. Storb, B. Sandmaier, 2003, Experimental hematology.

Prolonged allogeneic marrow engraftment following nonmyeloablative conditioning using 100 cGy total body irradiation and pentostatin before and pharmacological immunosuppression after transplantation.

J. Panse, R. Storb, B. Sandmaier, 2005, Transplantation.

Multi‐centre validation of the prognostic value of the haematopoietic cell transplantation‐ specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation

M. Sorror, M. Maris, R. Storb, 2015, British journal of haematology.

Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

J. Radich, M. Sorror, R. Storb, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impacts of Cytogenetic Abnormalities and Prior Alemtuzumab on Outcomes of Patients (pts) with High-Risk Chronic Lymphocytic Leukemia (CLL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT)

M. Sorror, R. Storb, B. Sandmaier, 2010 .

SYNERGISM BETWEEN IL-10 GENOTYPE OF PATIENT AND IL-10 RECEPTOR-β GENOTYPE OF DONOR

L. Zhao, Ming-Tseh Lin, B. Storer, 2005 .

Biological and clinical effects of interferon-beta ser at two doses.

B. Storer, E. Borden, D. Trump, 1990, Journal of interferon research.

Plasma lipoprotein changes in humans induced by β-interferon

B. Storer, E. Borden, D. Wiebe, 1987 .

Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept

E. Estey, H. Deeg, B. Storer, 2010, British journal of haematology.

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

M. Sorror, M. Maris, R. Storb, 2004 .

Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.

M. Maris, R. Storb, B. Sandmaier, 2019, The Lancet. Haematology.

Clinical benefit of response in chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2016, Blood.

Nephrolithiasis in pediatric hematopoietic cell transplantation with up to 40 years of follow‐up

B. Storer, K. Baker, S. Hingorani, 2014, Pediatric blood & cancer.

Pulmonary function in long‐term survivors of pediatric hematopoietic cell transplantation

B. Storer, D. Madtes, J. Sanders, 2006, Pediatric blood & cancer.

Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.

M. Sorror, M. Maris, R. Storb, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Nonmyeloablative and Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies: Outcomes with HLA-Matched Unrelated Donors Compared to HLA-Identical Sibling Donors.

M. Maris, R. Storb, B. Sandmaier, 2005 .

Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease

S. Mccarroll, D. Altshuler, L. Zhao, 2009, Nature Genetics.

Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20+ B-cell Malignancies.

R. Storb, B. Sandmaier, D. Maloney, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Statistical considerations in studies of late effects in HCT.

B. Storer, 2009, Biology of Blood and Marrow Transplantation.

Clinical and Immunological Effects of Granulocyte-Macrophage Colony-stimulating Factor Coadministered with Interleukin 2: A Phase IB Study 1

B. Storer, G. Wilding, P. Sondel, 2008 .

Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study.

B. Storer, G. Wilding, J. Schiller, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Repetitive weekly cycles of interleukin 2: effect of outpatient treatment with a lower dose of interleukin 2 on non-major histocompatibility complex-restricted killer activity.

R. Bechhofer, J. Sosman, B. Storer, 1989, Cancer research.

Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor.

L. Zhao, Ming-Tseh Lin, B. Storer, 2005, Blood.

Long‐term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

P. Hari, M. Sorror, M. Maris, 2015, Cancer.

Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.

M. Sorror, R. Storb, B. Sandmaier, 2008, Blood.

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia.

J. Radich, M. Maris, R. Storb, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Expressive Talking Among Caregivers of Hematopoietic Stem Cell Transplant Survivors: Acceptability and Concurrent Subjective, Objective, and Physiologic Indicators of Emotion

B. Storer, S. Langer, K. Syrjala, 2012, Journal of psychosocial oncology.

disease following prior therapy or antecedent hematologic disorders syndrome: similar outcomes in patients with de novo disease and syndrome or acute myeloid leukemia arising from myelodysplastic Hematopoietic cell transplantation in patients with myelodysplastic

B. Clurman, B. Sandmaier, B. Storer, 2013 .

Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders.

B. Clurman, H. Deeg, R. Storb, 2007, Blood.

Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy of total body irradiation.

M. Sorror, R. Storb, F. Baron, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation.

A. Nademanee, N. Kröger, B. Storer, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources.

M. Sorror, R. Storb, B. Sandmaier, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation.

R. Storb, B. Sandmaier, B. Storer, 2011, Cytotherapy.

Immunomodulatory effects induced by CTLA4-Ig with donor PBMC infusion in canine MHC-haploidentical nonmyeloablative hematopoietic cell transplantation

R. Storb, B. Sandmaier, B. Storer, 2011 .

Myeloablative Versus Nonmyeloablative Hemopoietic Cell Transplantation (HCT) for Patients with Myelodysplasia (MDS) or AML with Multilineage Dysplasia Following MDS (tAML).

M. Sorror, M. Maris, R. Storb, 2004 .

Treatment of patients (pts) with chemotherapy-refractory chronic lymphocytic leukemia (CLL) with nonmyeloablative (NM) conditioning and hematopoietic cell transplantation (HCT) from HLA-matched related (MRD) or unrelated donors (URD)

M. Sorror, M. Maris, R. Storb, 2004 .

Long-term Outcomes with Nonmyeloablative HLA-Identical Related Hematopoietic Cell Transplantation Using Tacrolimus and Mycophenolate Mofetil for Graft-versus-Host Disease Prophylaxis.

R. Storb, B. Sandmaier, D. Maloney, 2021, Transplantation and cellular therapy.

Long-term Outcomes with Nonmyeloablative HLA-Identical Related Hematopoietic Cell Transplantation Using Tacrolimus and Mycophenolate Mofetil for Graft-versus-Host Disease Prophylaxis.

Brenda, R. Storb, D. Maloney, 2021, Transplantation and cellular therapy.

Low T cell receptor excision circle levels in patients thymectomized 25-54 years ago.

D. Douek, D. Maloney, B. Storer, 2003, Immunology letters.

Canine DLA-79 gene: an improved typing method, identification of new alleles and its role in graft rejection and graft-versus-host disease.

R. Storb, B. Storer, D. Geraghty, 2013, Tissue antigens.

Targeted Busulfan and Cyclophosphamide as Compared to Busulfan and TBI as Preparative Regimens for Transplantation in Patients with Advanced MDS or Transformation to AML

H. Deeg, B. Storer, F. Appelbaum, 2004, Leukemia & lymphoma.

Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma.

M. Sorror, R. Storb, D. Maloney, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relationship of body mass index and arm anthropometry to outcomes after pediatric allogeneic hematopoietic cell transplantation for hematologic malignancies.

B. Storer, P. Carpenter, K. Baker, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Anti‐thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II study

B. Storer, S. Petersdorf, A. Ramakrishnan, 2010, British journal of haematology.

Exact Properties of Some Exact Test Statistics for Comparing Two Binomial Proportions

Choongrak Kim, B. Storer, Choongrak Kim, 1990 .

Assignment of scores for the hematopoietic cell transplantation comorbidity index: integer vs exact weights

M. Sorror, R. Storb, B. Storer, 2011, Bone Marrow Transplantation.

Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes.

H. Deeg, Emily A. Stevens, M. Sorror, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Factors Determining Responses to Azacitidine in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Early Post-Transplantation Relapse: A Prospective Trial.

H. Deeg, B. Storer, Janghee Woo, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor Lymphocyte Infusion for Relapsed Hematological Malignancies After Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial CD3+ T Cell Dose

M. Bar, P. Hari, R. Storb, 2012 .

A Randomized 3-Arm Phase II Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute Graft-Versus-Host Disease (GVHD) After Unrelated Donor Hematopoietic Cell Transplantation (HCT) Using Nonmyeloablative Conditioning for Patients with Hematologic Malignancies: A M

M. Maris, R. Storb, B. Sandmaier, 2009 .

Limited Utility of Outpatient Surveillance Blood Cultures in Hematopoietic Cell Transplant Recipients on High-Dose Steroids for Treatment of Acute Graft-versus-Host-Disease.

B. Storer, L. Bourassa, M. Mielcarek, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation following minimal intensity conditioning: predicting acute graft-versus-host disease and graft-versus-tumor effects.

M. Sorror, R. Storb, B. Sandmaier, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved Survival Following HLA-Matched Related Marrow Transplantation in Pediatric Patients with Severe Aplastic Anemia: (A 39-Year Retrospective Analysis)

R. Storb, B. Storer, H. Deeg, 2011 .

genotype of donor β synergism between IL-10 genotype of patient and IL-10 receptor graft-versus-host disease following hematopoietic cell transplantation: Genetic variation in the IL-10 pathway modulates severity of acute

L. Zhao, Ming-Tseh Lin, B. Storer, 2013 .

IL 10 AND IL 10 RECEPTOR GENE VARIATION AND OUTCOMES AFTER UNRELATED AND RELATED HEMATOPOIETIC CELL TRANSPLANTATION

L. Zhao, Ming-Tseh Lin, B. Storer, 2009 .

304: Effect of Substituting Fludarabine and Thymoglobulin for Cyclophosphamide in Busulfan-based Conditioning Regimens on T-cell Chimerism and outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)

S. Heimfeld, M. Sorror, B. Storer, 2008 .

Reduced Incidence of Acute and Chronic Graft-versus-Host Disease (GvHD) without Increased Relapse in Patients with High-Risk Myeloid Disorders Given Thymoglobulin (THY) as Part of the Transplant Conditioning Regimen: A Dose-Finding Study.

R. Storb, B. Storer, G. McDonald, 2004 .

Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning for Patients (pts) Aged ≥60 Years.

M. Sorror, M. Maris, R. Storb, 2008 .

Prospective Phase II Multicenter Study of Conditioning with Treosulfan, Fludarabine and Low-Dose (2 Gy) Total Body Irradiation Followed by Hematopoietic Cell Transplantation From Related or Unrelated Donors for Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

H. Deeg, M. Bar, B. Storer, 2012 .

Treatment of Recurrent or Persistent AML/MDS After Allogeneic Hematopoietic Cell Transplantation with Azacitidine.

E. Estey, R. Storb, B. Sandmaier, 2010 .

A Modified Hematopoietic Cell Transplantation (HCT)-Specific-Comorbidity Index.

M. Sorror, R. Storb, F. Baron, 2004 .

Prognostic Factors And Outcomes Of Severe Gastrointestinal Graft-Vs-Host Disease (GI GVHD) After Allogeneic Hematopoietic Cell Transplantation

B. Storer, G. McDonald, R. Nash, 2009 .

M. Maris, R. Storb, B. Sandmaier, 2004 .

Retrospective comparison of clofarabine versus fludarabine in combination with high-dose cytarabine with or without granulocyte colony-stimulating factor as salvage therapies for acute myeloid leukemia

E. Estey, B. Storer, F. Appelbaum, 2013, Haematologica.

Nonmyeloablative hematopoietic cell transplantation (HCT) for treatment of patients (pts) with fludarabine-refractory chronic lymphocytic leukemia (CLL) results in prolonged median survival.

J. Radich, R. Storb, B. Sandmaier, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relationship between Conditioning Intensity and Comorbidity in Patients (Pts) with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS) Receiving Allogeneic Hematopoietic Cell Transplantation (HCT).

M. Sorror, M. Maris, R. Storb, 2005 .

Second Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies for Relapse After First Allografts

R. Storb, B. Sandmaier, D. Maloney, 2012 .

Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning

R. Storb, B. Sandmaier, B. Storer, 2005, Bone Marrow Transplantation.

Treatment for Acute Myelogenous Leukemia by Low Dose Irradiation Based Conditioning and Hematopoietic Cell Transplantation from Related and Unrelated Donors.

M. Maris, R. Storb, B. Sandmaier, 2004 .

Higher Doses of Transplanted CD34+, CD3+ and CD8+ Cells Are Associated with Better Donor T-Cell Chimerism and Less Graft Rejection, but Not with GVHD after Nonmyeloablative Conditioning for Unrelated Hematopoietic Cell Transplantation.

S. Heimfeld, J. Panse, M. Sorror, 2004 .

Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia.

E. Estey, M. Sorror, B. Sandmaier, 2021, Blood.

Replication of associations between genetic polymorphisms and chronic graft-versus-host disease.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, L. Zhao, 2016, Blood.

Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant

B. Storer, M. Flowers, P. Martin, 2017, Bone Marrow Transplantation.

Parental age in relation to risk of breast cancer.

A. Trentham-Dietz, P. Newcomb, B. Storer, 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Fracture history and risk of breast and endometrial cancer.

W. Willett, M. Stampfer, J. Baron, 2001, American journal of epidemiology.

Weight change and risk of postmenopausal breast cancer (United States)

W. Willett, M. Stampfer, J. Baron, 2000, Cancer Causes & Control.

Alcohol consumption in relation to endometrial cancer risk.

Hormonal risk factors for endometrial cancer: modification by cigarette smoking (United States)

A. Trentham-Dietz, P. Newcomb, B. Storer, 2001, Cancer Causes & Control.

Detection method and breast carcinoma histology

J. Potter, A. Trentham-Dietz, P. Newcomb, 2002, Cancer.

Cigarette smoking in relation to risk of large bowel cancer in women.

P. Newcomb, P. Marcus, B. Storer, 1995, Cancer research.

Early adulthood physical activity and colon cancer risk among Wisconsin women.

P. Newcomb, P. Marcus, B. Storer, 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Comparison of case‐deletion diagnostic methods for Cox regression

B. Storer, Hsiao‐Mei Wang, Michael P. Jones, 2006, Statistics in medicine.

Postmenopausal hormone use and risk of large-bowel cancer.

P. Newcomb, B. Storer, 1995, Journal of the National Cancer Institute.

Recent oral contraceptive use and risk of breast cancer (United States)

W. Willett, M. Longnecker, J. Baron, 1996, Cancer Causes & Control.

Self‐reported stress and risk of breast cancer

A. Trentham-Dietz, P. Newcomb, B. Storer, 1996, Cancer.

Allogeneic peripheral blood stem cell graft composition affects early T‐cell chimaerism and later clinical outcomes after non‐myeloablative conditioning

S. Heimfeld, M. Maris, R. Storb, 2005, British journal of haematology.

Pregnancy termination in relation to risk of breast cancer.

W. Willett, M. Longnecker, P. Newcomb, 1996, JAMA.

A note on Box-Cox transformation diagnostics

Choongrak Kim, Meeseon Jeong, B. Storer, 1996 .

Maximum Likelihood Fitting of General Risk Models to Stratified Data

Norman E. Breslow, Sholom Wacholder, N. Breslow, 1983 .

Usual consumption of plant foods containing phytoestrogens and sex hormone levels in postmenopausal women in Wisconsin.

R. Klein, B. Klein, S. Haffner, 1998, Nutrition and cancer.

The association of body size and large bowel cancer risk in Wisconsin (United States) women

P. Newcomb, B. Storer, A. T. Dietz, 2004, Cancer Causes & Control.

Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing.

B. Storer, N. Roper, R. Bona, 2010, Journal of Molecular Diagnostics.

General relative risk functions for case-control studies.

N E Breslow, B E Storer, N. Breslow, 1985, American journal of epidemiology.

Serious Acute or Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplantation: A Comparison of Myeloablative and Non-Myeloablative Conditioning Regimens.

M. Sorror, R. Storb, B. Sandmaier, 2006 .

Cigarette Smoking and Breast Cancer 1

M. Longnecker, J. Baron, P. Newcomb, 2005 .

Risk Factors for the Development of Acute and National Institute of Health (NIH) Chronic Graft-Versus-Host Disease (GVHD).

B. Storer, F. Appelbaum, P. Campregher, 2009 .

Further studies on skin melanomas apparently dependent on female sex hormones.

B. Storer, J. A. Lee, 1982, International journal of epidemiology.

Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.

P. Remington, A. Trentham-Dietz, P. Newcomb, 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Revised Acute Myeloid Leukemia Composite Model Using the 2017 European LeukemiaNet Risk Classification.

E. Estey, M. Sorror, B. Storer, 2019, JAMA oncology.

The association of reproductive and menstrual characteristics and colon and rectal cancer risk in Wisconsin women.

T. Young, P. Newcomb, P. Marcus, 1995, Annals of epidemiology.

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes At US Transplant Centers: A Center for International Blood and Marrow Transplant Research (CIBMTR) Study

M. Sorror, B. Storer, M. Pasquini, 2012 .

Impact of Pretransplant Neutropenia on Post-Transplant Outcome in Patients with Myelodysplastic Syndrome (MDS).

B. Storer, M. Boeckh, K. Marr, 2006 .

Adjuvant radiation therapy and chemotherapy in Merkel cell carcinoma: Survival analysis of 6,908 cases from the National Cancer Data Base.

V. Sondak, B. Storer, J. Gershenwald, 2014 .

A Reanalysis of the Stanford Heart Transplant Data: Comment

J. Crowley, B. Storer, John Crowley, 1983 .

Recipient and donor genetic variants associated with mortality after allogeneic hematopoietic cell transplantation.

B. Storer, J. Hansen, S. Nelson, 2020, Blood advances.

Phase 1 clinical evaluation of recombinant interleukin-2.

R. Bechhofer, B. Storer, K. Moore, 1987, Progress in clinical and biological research.

Improving hematopoietic cell transplant outcomes in a new era of genomic research.

L. Zhao, B. Storer, E. Warren, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Preoperative MRI improves prediction of extensive occult axillary lymph node metastases in breast cancer patients with a positive sentinel lymph node biopsy.

D. Mankoff, C. Lehman, S. Peacock, 2014, Academic radiology.

Incorporating Physical Function and Cognition Into Mortality Risk Assessment for Acute Myeloid Leukemia-Reply.

E. Estey, M. Sorror, B. Storer, 2018, JAMA Oncology.

Sustained Graft-Versus-Lymphoma Effect among Patients (pts) with Mantle Cell Lymphoma (MCL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT).

M. Sorror, M. Maris, R. Storb, 2008 .

Confounding Factors Affecting the National Institutes of Health (NIH) Chronic GVHD Organ-Specific Score and Global Severity

B. Storer, Stephanie J. Lee, M. Flowers, 2014 .

Multi-Institutional Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes

M. Sorror, R. Storb, B. Sandmaier, 2011 .

Low Albumin, High Ferritin, and Thrombocytopenia Before Transplant Predict Non-Relapse Mortality (NRM) Independent of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI).

M. Sorror, R. Storb, B. Sandmaier, 2009 .

An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm AML patients.

E. Estey, M. Sorror, B. Sandmaier, 2022, Blood.

Nonsteroidal Anti-inflammatory Drug Use and Protection against Colorectal Cancer in Women 1

P. Remington, A. Trentham-Dietz, P. Newcomb, 2005 .

Benchmarks in clinical productivity: a national comprehensive cancer network survey.

C. Bloomfield, S. Perkel, M. Waldinger, 2007, Journal of oncology practice.

Cirrhosis of the liver in long-term marrow transplant survivors.

K. Sullivan, B. Storer, G. McDonald, 1999, Blood.

Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation

B. Storer, J. Pidala, Stephanie J. Lee, 2015 .

Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).

B. Storer, D. Coldwell, N. Patel, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Donor CMV Serostatus Not Predictive of Relapse in D-/R- Pediatric HCT

M. Sorror, R. Storb, B. Storer, 2009 .

Differential Effects of HOXB4 on Nonhuman Primate Short- and Long-Term Repopulating Cells

B. Storer, R. Humphries, H. Kiem, 2006, PLoS medicine.

Relapse Risk after Nonmyeloablative Hematopoietic Cell Transplantation for Malignant Diseases.

M. Maris, R. Storb, B. Sandmaier, 2005 .

Antilymphoma activity of human gamma delta T-cells in mice with severe combined immune deficiency.

B. Storer, N. Armstrong, R. Hong, 1992, Cancer research.

Comorbidity, Lactate Dehydrogenase (LDH), and Chemosensitivity Are Independent Predictors of Mortality after Autologous Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Lymphoma.

M. Sorror, R. Storb, B. Sandmaier, 2007 .

Transplantation Infection Rates between Days 100 and 365 after Allogeneic Marrow Low B-cell and Monocyte Counts on Day 80 Are Associated with High

D. Maloney, B. Storer, M. Flowers, 2022 .

Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning after Failed Myeloablative HCT: Factors Affecting Outcomes.

M. Sorror, R. Storb, F. Baron, 2005 .

Estimation of Cumulative Incidence in the Presence of Competing Risks

J. Crowley, B. Storer, W. Leisenring, 2005 .

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients with De Novo and Secondary Acute Myeloid Leukemia

M. Maris, R. Storb, B. Sandmaier, 2008 .

Long-term outcomes with nonmyeloablative HLA-identical related HCT using tacrolimus and MMF for GVHD prophylaxis

Brenda, R. Storb, D. Maloney, 2021 .

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

B. Storer, J. Pidala, Stephanie J. Lee, 2011, Blood.

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2017, Blood.

Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013, Blood.

Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.

B. Storer, F. Appelbaum, E. Warren, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

H. Deeg, J. Radich, R. Storb, 2002, Blood.

Prevalence of Chromosomally Integr 6 in Patients with Human Herpesvir ated Human Herpesvirus us 6 e Central Nervous System Dysfunction

M. Sorror, R. Storb, B. Sandmaier, 2015 .

Phase I Trial of Clofarabine and High Dose Cytarabine with G-CSF Priming (G-CLAC) for Relapsed or Refractory Acute Myeloid Leukemia

E. Estey, B. Storer, F. Appelbaum, 2008 .

G-CSF Priming, Clofarabine and High Dose Cytarabine (GCLAC) for Relapsed or Refractory Acute Myeloid Leukemia (AML).

E. Estey, B. Storer, F. Appelbaum, 2009 .

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.

B. Storer, M. Boeckh, M. Flowers, 2009, Blood.

Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow.

R. Storb, B. Storer, F. Appelbaum, 2012, Blood.

Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system.

V. Sondak, M. Ross, B. Storer, 2010, Journal of the American Academy of Dermatology.

Immunomodulatory Effects of Mixed Hematopoietic Chimerism: Immune Tolerance in Canine Model of Lung Transplantation

R. Glenny, H. Ochs, R. Storb, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Survival Differences Among Patients (pts) with Acute Myeloid Leukemia (AML) Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Non-HCT Therapies: A Large Real-Time Multi-Center Prospective Longitudinal Observational Study

E. Estey, M. Sorror, B. Sandmaier, 2018, Blood.

Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma.

R. Fanin, A. Levis, M. Boccadoro, 2010, Blood.

Aspects of the breeding ecology of the pygmy nuthatch ( Sitta pygmaea) and the foraging ecology of wintering mixed-species flocks in western Montana

B. Storer, 1977 .

Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients.

D. Silbergeld, D. Born, K. Swanson, 2014, Journal of Clinical Investigation.

Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia

E. Estey, J. Davison, S. Heimfeld, 2015, Epigenetics.

Ixazomib for Treatment of Refractory Chronic Graft Vs. Host Disease: A Chronic Gvhd Consortium Phase II Trial

W. Wood, B. Storer, J. Pidala, 2019, Biology of Blood and Marrow Transplantation.

Preoperative MRI improves prediction of extensive occult axillary lymph node metastases in breast cancer patients with a positive sentinel lymph node biopsy.

D. Mankoff, C. Lehman, S. Peacock, 2014, Academic radiology.

Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia.

B. Storer, A. Woolfrey, M. Flowers, 2011, Blood.